Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 82


The clinical effects of probiotics for inflammatory bowel disease: A meta-analysis.

Jia K, Tong X, Wang R, Song X.

Medicine (Baltimore). 2018 Dec;97(51):e13792. doi: 10.1097/MD.0000000000013792.


Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy.

Mancini A, Campagna F, Amodio P, Tuohy KM.

Food Funct. 2018 Mar 1;9(3):1373-1388. doi: 10.1039/c7fo01528c. Epub 2018 Feb 27. Review.


The effects of probiotics on total cholesterol: A meta-analysis of randomized controlled trials.

Wang L, Guo MJ, Gao Q, Yang JF, Yang L, Pang XL, Jiang XJ.

Medicine (Baltimore). 2018 Feb;97(5):e9679. doi: 10.1097/MD.0000000000009679.


Effects of probiotic VSL#3 on glomerular filtration rate in dogs affected by chronic kidney disease: A pilot study.

Lippi I, Perondi F, Ceccherini G, Marchetti V, Guidi G.

Can Vet J. 2017 Dec;58(12):1301-1305.


Probiotics Ingestion Does Not Directly Affect Thyroid Hormonal Parameters in Hypothyroid Patients on Levothyroxine Treatment.

Spaggiari G, Brigante G, De Vincentis S, Cattini U, Roli L, De Santis MC, Baraldi E, Tagliavini S, Varani M, Trenti T, Rochira V, Simoni M, Santi D.

Front Endocrinol (Lausanne). 2017 Nov 14;8:316. doi: 10.3389/fendo.2017.00316. eCollection 2017.


Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.

Derwa Y, Gracie DJ, Hamlin PJ, Ford AC.

Aliment Pharmacol Ther. 2017 Aug;46(4):389-400. doi: 10.1111/apt.14203. Epub 2017 Jun 27. Review.


Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.

Ma C, Panaccione R, Fedorak RN, Parker CE, Khanna R, Levesque BG, Sandborn WJ, Feagan BG, Jairath V.

BMJ Open. 2017 Jun 9;7(6):e016146. doi: 10.1136/bmjopen-2017-016146.


Probiotics for people with hepatic encephalopathy.

Dalal R, McGee RG, Riordan SM, Webster AC.

Cochrane Database Syst Rev. 2017 Feb 23;2:CD008716. doi: 10.1002/14651858.CD008716.pub3. Review.


Comparative Effect of the I3.1 Probiotic Formula in Two Animal Models of Colitis.

Lorén V, Manyé J, Fuentes MC, Cabré E, Ojanguren I, Espadaler J.

Probiotics Antimicrob Proteins. 2017 Mar;9(1):71-80. doi: 10.1007/s12602-016-9239-5.


Effects of a Multispecies Probiotic Mixture on Glycemic Control and Inflammatory Status in Women with Gestational Diabetes: A Randomized Controlled Clinical Trial.

Jafarnejad S, Saremi S, Jafarnejad F, Arab A.

J Nutr Metab. 2016;2016:5190846. doi: 10.1155/2016/5190846. Epub 2016 Jun 26.


A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer.

Lacouture ME, Keefe DM, Sonis S, Jatoi A, Gernhardt D, Wang T, Doherty JP, Giri N, Nadanaciva S, O'Connell J, Sbar E, Piperdi B, Garon EB.

Ann Oncol. 2016 Sep;27(9):1712-8. doi: 10.1093/annonc/mdw227. Epub 2016 Jun 10.


Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.

Singh S, Stroud AM, Holubar SD, Sandborn WJ, Pardi DS.

Cochrane Database Syst Rev. 2015 Nov 23;(11):CD001176. doi: 10.1002/14651858.CD001176.pub3. Review.


Probiotic supplementation attenuates increases in body mass and fat mass during high-fat diet in healthy young adults.

Osterberg KL, Boutagy NE, McMillan RP, Stevens JR, Frisard MI, Kavanaugh JW, Davy BM, Davy KP, Hulver MW.

Obesity (Silver Spring). 2015 Dec;23(12):2364-70. doi: 10.1002/oby.21230. Epub 2015 Oct 14.


Probiotic supplementation and trimethylamine-N-oxide production following a high-fat diet.

Boutagy NE, Neilson AP, Osterberg KL, Smithson AT, Englund TR, Davy BM, Hulver MW, Davy KP.

Obesity (Silver Spring). 2015 Dec;23(12):2357-63. doi: 10.1002/oby.21212. Epub 2015 Oct 14.


VSL#3 induces and maintains short-term clinical response in patients with active microscopic colitis: a two-phase randomised clinical trial.

Rohatgi S, Ahuja V, Makharia GK, Rai T, Das P, Dattagupta S, Mishra V, Garg SK.

BMJ Open Gastroenterol. 2015 Feb 9;2(1):e000018. doi: 10.1136/bmjgast-2014-000018. eCollection 2015.


Impact of diet and nutraceutical supplementation on inflammation in elderly people. Results from the RISTOMED study, an open-label randomized control trial.

Ostan R, Béné MC, Spazzafumo L, Pinto A, Donini LM, Pryen F, Charrouf Z, Valentini L, Lochs H, Bourdel-Marchasson I, Blanc-Bisson C, Buccolini F, Brigidi P, Franceschi C, d'Alessio PA.

Clin Nutr. 2016 Aug;35(4):812-8. doi: 10.1016/j.clnu.2015.06.010. Epub 2015 Jul 15.


Role of probiotics VSL#3 in prevention of suspected sepsis in low birthweight infants in India: a randomised controlled trial.

Sinha A, Gupta SS, Chellani H, Maliye C, Kumari V, Arya S, Garg BS, Gaur SD, Gaind R, Deotale V, Taywade M, Prasad MS, Thavraj V, Mukherjee A, Roy M.

BMJ Open. 2015 Jul 10;5(7):e006564. doi: 10.1136/bmjopen-2014-006564.


Administration of a multistrain probiotic product (VSL#3) to women in the perinatal period differentially affects breast milk beneficial microbiota in relation to mode of delivery.

Mastromarino P, Capobianco D, Miccheli A, Praticò G, Campagna G, Laforgia N, Capursi T, Baldassarre ME.

Pharmacol Res. 2015 May-Jun;95-96:63-70. doi: 10.1016/j.phrs.2015.03.013. Epub 2015 Mar 31.


Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment.

Miccheli A, Capuani G, Marini F, Tomassini A, Praticò G, Ceccarelli S, Gnani D, Baviera G, Alisi A, Putignani L, Nobili V.

Int J Obes (Lond). 2015 Jul;39(7):1118-25. doi: 10.1038/ijo.2015.40. Epub 2015 Mar 26.


The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.

Fedorak RN, Feagan BG, Hotte N, Leddin D, Dieleman LA, Petrunia DM, Enns R, Bitton A, Chiba N, Paré P, Rostom A, Marshall J, Depew W, Bernstein CN, Panaccione R, Aumais G, Steinhart AH, Cockeram A, Bailey RJ, Gionchetti P, Wong C, Madsen K.

Clin Gastroenterol Hepatol. 2015 May;13(5):928-35.e2. doi: 10.1016/j.cgh.2014.10.031. Epub 2014 Nov 6.


Supplemental Content

Loading ...
Support Center